N. Chinnasamy

发表

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Tongguang Wang, Dolores J. Schendel, Richard A. Morgan, 2013, Journal of immunotherapy.

Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins.

R. Morgan, F. Candotti, M. Otsu, 2000, Blood.

Lentiviral-mediated gene transfer into human lymphocytes: role of HIV-1 accessory proteins.

R. Morgan, F. Candotti, M. Otsu, 2000, Blood.

Development of an Avian Leukosis-Sarcoma Virus Subgroup A Pseudotyped Lentiviral Vector

H. Varmus, R. Morgan, B. Lewis, 2001, Journal of Virology.

Enhancing hemopoietic drug resistance: A rationale for reconsidering the clinical use of mitozolomide

N. Chinnasamy, D. Chinnasamy, L. Fairbairn, 2000, Cancer Gene Therapy.

Chemoprotective gene transfer II: multilineage in vivo protection of haemopoiesis against the effects of an antitumour agent by expression of a mutant human O6-alkylguanine-DNA alkyltransferase

T. Dexter, G. Margison, N. Chinnasamy, 1998, Gene Therapy.

Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry

R. Morgan, Zhili Zheng, N. Chinnasamy, 2012, Journal of Translational Medicine.

Evaluation of &ggr;-Retroviral Vectors That Mediate the Inducible Expression of IL-12 for Clinical Application

S. Rosenberg, R. Morgan, M. Dudley, 2012, Journal of immunotherapy.

Development of a T Cell Receptor Targeting an HLA-A*0201 Restricted Epitope from the Cancer-Testis Antigen SSX2 for Adoptive Immunotherapy of Cancer

S. Rosenberg, D. Speiser, R. Morgan, 2014, PloS one.

Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors.

P. Hwu, R. Morgan, F. Candotti, 2000, Human gene therapy.

Chemoprotection of normal tissues by transfer of drug resistance genes

T. Dexter, G. Margison, N. Chinnasamy, 1996, Cancer and Metastasis Reviews.

Protection of committed murine haemopoietic progenitors against BCNU toxicity does not predict protection of primitive, multipotent spleen colony-forming cells – implications for chemoprotective gene therapy

T. Dexter, G. Margison, N. Chinnasamy, 1999, Leukemia.

Genotoxicity studies on the azo dye Direct Red 2 using the in vivo mouse bone marrow micronucleus test.

J. Ashby, S. Turner, N. Chinnasamy, 1999, Mutation research.

Multicistronic lentiviral vectors containing the FMDV 2A cleavage factor demonstrate robust expression of encoded genes at limiting MOI

G. Margison, N. Chinnasamy, D. Chinnasamy, 2006, Virology Journal.

Lentivirus-mediated expression of mutant MGMTP140K protects human CD34+ cells against the combined toxicity of O6-benzylguanine and 1,3-bis(2-chloroethyl)-nitrosourea or temozolomide.

G. Margison, N. Chinnasamy, J. Treisman, 2004, Human gene therapy.

Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer.

R. Morgan, S. Xi, Julie A Hong, 2011, Cancer research.

Inhibition of Histone Lysine Methylation Enhances Expression of Cancer-Testis Genes in Lung Cancer Cells: Implications for Adoptive Immunotherapy of Cancer

R. Morgan, S. Xi, Julie A Hong, 2011 .

Plasmid DNA vaccine encoding prostatic acid phosphatase is effective in eliciting autologous antigen-specific CD8+ T cells

D. McNeel, T. Frye, N. Chinnasamy, 2007, Cancer Immunology, Immunotherapy.

Differential Requirements for Hematopoietic Commitment Between Human and Rhesus Embryonic Stem Cells

J. Thomson, S. Mitalipov, D. Wolf, 2007, Stem cells.

Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging

H. Huynh, P. Lam, K. Hui, 2012, Gene Therapy.

Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination

N. Chinnasamy, M. Oaks, J. Treisman, 2005, Gene Therapy.

Chemoprotective gene transfer I: transduction of human haemopoietic progenitors with O6-benzylguanine-resistant O6-alkylguanine-DNA alkyltransferase attenuates the toxic effects of O6-alkylating agents in vitro

T. Dexter, G. Margison, N. Chinnasamy, 1998, Gene Therapy.

Production of multicistronic HIV-1 based lentiviral vectors.

N. Chinnasamy, D. Chinnasamy, J. Shaffer, 2009, Methods in molecular biology.

Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.

H. Fine, Wei Zhang, S. Rosenberg, 2012, Human gene therapy.

Modulation of O6-alkylating agent induced clastogenicity by enhanced DNA repair capacity of bone marrow cells.

N. Chinnasamy, L. Fairbairn, J. Laher, 1998, Mutation research.

O6-benzylguanine potentiates the in vivo toxicity and clastogenicity of temozolomide and BCNU in mouse bone marrow.

J. Ashby, G. Margison, T. Dexter, 1997, Blood.

- Benzylguanine Potentiates the In Vivo Toxicity and Clastogenicity of Temozolomide and BCNU in Mouse Bone Marrow

J. Ashby, G. Margison, T. Dexter, 1997 .

Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression.

R. Morgan, G. Lizée, J. Aerts, 2003, Human gene therapy.

A TCR Targeting the HLA-A*0201–Restricted Epitope of MAGE-A3 Recognizes Multiple Epitopes of the MAGE-A Antigen Superfamily in Several Types of Cancer

J. Wargo, S. Rosenberg, R. Morgan, 2011, The Journal of Immunology.

RECENT PROGRESS AND FUTURE DIRECTIONS USING ENGINEERED T CELLS FOR THE TREATMENT OF CANCER

R. Morgan, N. Chinnasamy, 2010 .

Protein L: a novel reagent for the detection of Chimeric Antigen Receptor (CAR) expression by flow cytometry

R. Morgan, N. Chinnasamy, Z. Zheng, 2012, Journal of Translational Medicine.

Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging

H. Huynh, P. Lam, K. Hui, 2011, Gene Therapy.

Induction of O6-alkylguanine-DNA-alkyltransferase in the hepatocytes of rats following treatment with 2-acetylaminofluorene.

G. Margison, P. O'connor, N. Chinnasamy, 1997, DNA and Cell Biology.

A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4

M. Tector, N. Chinnasamy, Karen M. Kozinski, 2006, Cancer Immunology, Immunotherapy.